News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Stratagene Expects Fourth Quarter Revenue Of Approximately $24.7 Million


2/1/2007 12:47:34 PM

LA JOLLA, Calif.--(BUSINESS WIRE)--Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostic products, today announced preliminary revenue results for the fourth quarter of 2006 ended December 31, 2006. Revenue is expected to be approximately $24.7 million, an increase of 7.2% compared with pro forma revenue of $23.0 million in the fourth quarter of 2005. Full year revenue is expected to be approximately $95.6 million.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES